Sign in
Active, not recruitingPhase 2

Determining the Potential for Efficacy of OTX-601 in Reducing PTSD Symptoms

Key facts

Who runs it
Oui Therapeutics, Inc.
Where
Tallahassee, United StatesSee the site
Trial code
Status
Active, not recruiting
Phase
Phase 2
People taking part
40 people, planned
Started
9 Dec 2025
Ended
17 Aug 2026
Type of study
Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
Treatments tested
  • OTX-601 Digital Therapeutic
  • OTX-003 Comparator app
Record updated
15 July 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • Posttraumatic stress disorder (PTSD) diagnosis
  • Anxiety Sensitivity Index 3 (ASI-3) scores above 24
  • PTSD Checklist for DSM-V (PCL-5) scores above 30
  • Understands and speaks English
  • Access to a smartphone that is connected to the internet

Who cannot take part

  • Medical illness that would prevent the completion of interoceptive exposure exercises
  • Score of 24 or lower on the ASI-3
  • Score of 30 and below on the PCL-5
  • No PTSD diagnosis
  • Active psychosis
  • Acute intoxication during study baseline
  • Enrolled in another treatment research study

Where in United States

  • Florida State UniversityTallahassee, United States

About the trial

What the trial wants to find out

This study is exploring the efficacy of a digital therapeutic app in reducing symptoms of posttraumatic stress disorder (PTSD) in adults.

The 2 groups in the trial

  • OTX-601Treatment being tested

    A prescription digital therapeutic designed to overcome existing barriers and deliver evidence based treatment for PTSD

    Treatment: OTX-601 Digital Therapeutic

  • OTX-003Sham treatment, for comparison

    OTX-003 is a smartphone application developed as a comparator to OTX-601 and designed to match its interface while providing no active PTSD treatment.

    Treatment: OTX-003 Comparator app

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Determining the Potential for Efficacy of OTX-601 in Reducing PTSD Symptoms in a Randomized Controlled Trial (RCT)
Record updated
15 July 2026